Bioluminar

Regional Hubs

Bringing CAR T Cell Therapies Closer to Patients.

By leveraging established CAR T cell technologies, we're committed to developing treatments locally in our specialized labs. Our high-quality, regulated therapies will be distributed across our extensive network of partner medical centers, all pre-approved by insurance companies. This approach allows medical centers to prioritize the clinical aspects and application of these advanced therapies.

High Quality Regulated Therapies

Network of Partner Medical Centers

Application in Medical Centers

First Central Laboratory in Clinical Research

About Us

The MedLab is first laboratory in Clinical Research refers to the initial establishment of a laboratory that serves as a centralized facility for conducting various types of diagnostic tests and research studies in the field of medicine. By having a central laboratory, researchers and healthcare professionals can have access to standardized, high-quality testing services and results, which are critical for accurate diagnosis and effective treatment of diseases.

We're on the cusp of a revolution in cellular therapies, making now the pivotal moment for CAR T advancements in LatAm.

Closed systems technological advancements

Regulatory momentum, from clinical trials to approvals

New paradigm for personalized care

Localizing Advanced Cellular Therapies for LatAm

Bridging the gap between groundbreaking CAR T innovations and the patients who need them the most.

Bridging the Innovation Gap

Acting as the essential link between hospitals and the latest cellular therapy developments.

Expertise in Local Landscape

Deep insights into local reimbursement, commercialization, and regulatory ecosystems.

Collaboration with IP partners

Licensing proprietary IP from leading institutions to become LatAm's premier manufacturer and provider of cellular treatments.

Partnerships with Medical Institutions

Ensuring hospitals and clinics provide their patients with top-tier therapies at competitive prices.

Simplified Operations

Minimizing logistical challenges, ensuring adherence to local regulations, and emphasizing local manufacturing.

Regional Hubs: Bringing CAR T Therapies Closer to Patients

By importing and leveraging established CAR-T intellectual property, we're committed to developing treatments locally in our specialized labs.

Our high-quality, regulated therapies will then be seamlessly distributed across our extensive network of partner medical centers, all pre-approved by insurance companies.

This approach allows medical centers to prioritize the clinical aspects and application of these advanced therapies.

Services

Our Popular Laboratory Test Services.

Remarkable Remissions

Specific targeted CAR T cells can induce prolonged remissions in patients with particular malignancies, often with low long-term toxicities, and potentially curative for a subset of patients.

Learn More

Prolonged Survival

CAR T therapies represent a remarkable blend of cellular therapy, immunotherapy, and gene therapy. They are not merely drugs, but "living" medicines infused into patients. As immunotherapies, they harness the body's immune cells to fight cancer cells. Moreover, they stand as pioneering gene therapies, with genetically engineered lymphocytes targeting and combating the disease.

Learn More

Novelty in Numbers

CAR T therapies have marked a new era in oncological care, with commercially approved treatments for certain cancers and numerous clinical trials paving the way for future advancements.

Learn More